Progress in Renal Transplantation A Single Center Study of 3359 Patients Over 25 Years
- 1 May 1995
- journal article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 221 (5) , 446-458
- https://doi.org/10.1097/00000658-199505000-00002
Abstract
The study analyzed 3359 consecutive renal transplant operations for patient and graft survival, including living related, cadaveric, and living unrelated patients. The analysis was separated into three groups according to immunosuppression and date of transplant. Improvements in renal transplantation in the past 25 years have been the result of better immunosuppression, organ preservation, and patient selection. A single transplant center's experience over a 25-year period was analyzed regarding patient and graft survival. Potential risk factors included patient demographics, tissue typing, donor characteristics, number of transplants, acute and chronic rejection, acute tubular necrosis, primary disease, and malignancy. The primary cause of graft loss was rejection. Improvement in cadaveric graft survival since 1987 with quadruple therapy was not apparent in living donor patients. Race continued to be a negative factor in graft survival. Avoiding previous mismatched antigens and the use of flow cytometry improved allograft survival. The leading cause of death in the past 7 years in cadaveric recipients was cardiac (52%). Improved graft survival in the past 25 years was related to 1) advances in immunosuppression, 2) better methods of cytotoxic antibody detection, and 3) human lymphocyte antigen match.Keywords
This publication has 29 references indexed in Scilit:
- Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantationThe Lancet, 1994
- Chronic rejection in renal transplant recipients – Risk factors and correlatesClinical Transplantation, 1994
- Donor‐specific transfusions in renal transplantationClinical Transplantation, 1994
- PERIPHERAL BLOOD CHIMERISM IN RENAL ALLOGRAFT RECIPIENTS TRANSFUSED WITH DONOR BONE MARROW1,2Transplantation, 1994
- The incidence of subsequent acute rejection following the treatment of refractory renal allograft rejection with mycophenolate mofetil (RS61443).1994
- Clinical and socioeconomic benefits of serological HLA-DR matching for renal transplantation over three eras of immunosuppression regimens at a single unit.1993
- Renal transplantation at the University of Wisconsin in the cyclosporine era.1993
- CYCLOSPORIN A IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM CADAVER DONORSThe Lancet, 1978
- KIDNEY PRESERVATION FOR TRANSPORTATIONThe Lancet, 1969
- SUCCESSFUL HOMOTRANSPLANTATION OF THE HUMAN KIDNEY BETWEEN IDENTICAL TWINSJAMA, 1956